For instance, Cyp46a1 overexpression has been associated with benefits in models of Huntington’s disease, spinal cerebellar ataxia, and Alzheimer’s disease [39,40,41,42,43,44] but may be detrimental in excitotoxicity models [5,10]. This evidence concerns the gene CYP46A1 and early-onset autosomal dominant Alzheimer disease.